An Explanatory Case on the Limitations of Lymph Node Staging in Recurrent Prostate Cancer

Genitourinary CancerRadio-Oncology

Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy

J Clin Oncol.

Zumsteg ZS, Daskivich TJ, Sandler HM

doi: 10.1200/JCO.2016.69.2509

Genitourinary CancerRadio-Oncology

Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients

BJU Int.

Crouzet S, Blana A, Murat FJ, Pasticier G, Brown SCW, Conti GN, Ganzer R, Chapet O, Gelet A, Chaussy CG, Robertson CN, Thuroff S, Ward JF

doi: 10.1111/bju.13766.

Genitourinary Cancer

A more extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille

BJU Int.

Maderthaner L, Furrer MA, Studer UE, Burkhard FC, Thalmann GN, Nguyen DP

doi: 10.1111/bju.13993.

Lymphoma

CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement

healthbook TIMS Oncology Hematology

Ring A, Müller A

doi: 10.36000/hbT.OH.2019.01.005

Genitourinary Cancer

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT

Urol Case Rep.

Gergelis KR, Remme DS, Choo CR

doi: 10.1016/j.eucr.2019.100985.

Genitourinary Cancer

Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy

J Urol.

Robertson NL, Sala E, Benz M, Landa J, Scardino P, Scher HI, Hricak H, Vargas HA

doi: 10.1016/j.juro.2017.02.071.

Genitourinary Cancer

Therapy Management of Metastatic Prostate Carcinoma in General Practice

healthbook TIMES Oncology Hematology

Meisel A

doi: 10.36000/hbT.OH.2019.01.004

Genitourinary Cancer

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Alexander Meisela,b

doi: 10.36000/hbT.OH.2019.02.007

Lymphoma

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin

healthbook Times Oncology Hematology

Schmidt A

doi: 10.36000/hbT.OH.2020.06.025

Related content

Salvage Radiotherapy for Biochemically Recurrent Prostate Cancer After Prostatectomy

Salvage high-intensity focused ultrasound (HIFU) for locally recurrent prostate cancer after failed radiation therapy: Multi-institutional analysis of 418 patients

A more extended lymph node dissection template at radical prostatectomy detects metastases in the common iliac region and in the fossa of Marcille

CD19-Directed CAR T Cells Treatment in a Patient With Refractory DLBCL and CNS Involvement

Isolated biopsy-proven recurrence of prostate carcinoma in the spermatic cord after radical prostatectomy detected with 11C-Choline PET/CT

Combined Whole Body and Multiparametric Prostate Magnetic Resonance Imaging as a 1-Step Approach to the Simultaneous Assessment of Local Recurrence and Metastatic Disease after Radical Prostatectomy

Therapy Management of Metastatic Prostate Carcinoma in General Practice

Genomic Testing for Advanced Prostate Cancer: Ready for Prime Time?

Hodgkin’s Lymphoma after Autologous Stem-Cell Transplantation: Effective Consolidation with Brentuximab Vedotin